Luis M Ruilope

30PUBLICATIONS
88CO-AUTHORS
Respiratory diseasesCardiology (incl. cardiovascular diseases)Psychosocial aspects of childbirth and perinatal mental healthMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Feb 12, 2026
Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.

Sara Vázquez-Sánchez, Ana Blasco, Marina Polo-Salguero

|Sep 13, 2025
Atrial Myopathy and Heart Failure: Immunomolecular Mechanisms and Clinical Implications.

Marta Gil Fernández, Andrea Bueno Sen, Paula Cantolla Pablo

|Jun 26, 2025
Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic (CKM) Syndrome.

Juan Guerrero-Mauvecin, Natalia Villar-Gómez, Lucia Miño-Izquierdo

|Mar 09, 2025
Cardiovascular disease in women with early-onset preeclampsia: a matched case-control study.

P Domínguez Del Olmo, I Herraiz, C Villalaín

|Feb 06, 2025
Is Fibroblast Growth Factor (FGF)23 a Player or a Trigger in Atrial Fibrillation?

José Alberto Navarro-García, Xander H T Wehrens, G Ruiz-Hurtado

|Jan 16, 2025
Recombinant Klotho administration after myocardial infarction reduces ischaemic injury and arrhythmias by blocking intracellular calcium mishandling and CaMKII activation.

Sara Vázquez-Sánchez, Ana Blasco, Pablo Fernández-Corredoira

Pageof 5

Frequent Collaborators

11 joint publications

Elena Rodríguez-Sánchez

4 joint publications

José Alberto Navarro-García

4 joint publications

María G Barderas

3 joint publications

Nerea Corbacho-Alonso